FindTrial
Sign In

To investigate the correlation between serum bile acid level less than 40 micro mol/L in pregnancies affected with intrahepatic cholestasis of pregnancy(liver problem associated to pregnancy) and maternal and fetal outcomes

To investigate correlation between raised serum bile acid levels in pregnancies affected with Intrahepatic Cholestasis of Pregnancy and adverse perinatal outcome. - IHCP40

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/10/016128
Enrollment
174
Registered
2018-10-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O266- Liver and biliary tract disordersin pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

Max Smart Super Speciality Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women presenting with pruritis with elevated liver enzymes Primigravida or Multigravida Spontaneous or IVF conception Singleton or Twins

Exclusion criteria

Exclusion criteria: History of cholelithiasis Chronic liver disease Hepatitis A,B,C,E Any other cause of raised liver function tests Dermatological cause of pruritis Allergic disorder Pre eclampsia and HELLP Patient refusal Patient with pruritis but no elevation of liver enzymes Pregnancy ending before 24 weeks gestation

Design outcomes

Primary

MeasureTime frame
To evaluate maternal and neonatal outcomes in Intrahepatic Cholestasis of pregnancy with Serum Bile Acids less than 40 micro mol per litre Timepoint: Until delivery—

Secondary

MeasureTime frame
To determine the frequency of serum bile acid measurement in these patientsTimepoint: 2 weeks;To determine the optimal timing of delivery with close monitoring in these patientsTimepoint: 40 weeks gestation—

Countries

India

Contacts

Public ContactDr Kiranjeet Kaur

A unit of Gujramal Modi hospital and Research Centre for Medical Sciences

kiranjeet.kaur@maxhealthcare.com9811253669

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026